Similar articles

• [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].

  Takada K, Morishita M, Sugiura T, Suzuki M, Torii Y, Ichimura K, Hashigami H, Toshikawa K, Ina Y, Yamamoto M, Oyama A, Urata A. Takada K, et al. Gan No Rinsho. 1983 Apr;29(4):A-19, 293-6. Gan No Rinsho. 1983. PMID: 6602233 Japanese.
• C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.

  Volanakis JE. Volanakis JE. Year Immunol. 1989;4:218-30. Year Immunol. 1989. PMID: 2648703 Review. No abstract available.
• Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.

  Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M. Mollnes TE, et al. Clin Exp Immunol. 1986 Jul;65(1):73-9. Clin Exp Immunol. 1986. PMID: 3641694 Free PMC article.
• [Structure and function of alternative pathway components of complement].

  Tomita M, Sugita Y. Tomita M, et al. Tanpakushitsu Kakusan Koso. 1986 Jul;31(9 Suppl):847-64. Tanpakushitsu Kakusan Koso. 1986. PMID: 3641329 Japanese. No abstract available.
• [Protein chemistry of the complement system].

  Nagasawa S. Nagasawa S. Tanpakushitsu Kakusan Koso. 1983 Jan;28(1):18-44. Tanpakushitsu Kakusan Koso. 1983. PMID: 6340167 Review. Japanese. No abstract available.